Adams Street Partners’s Veracyte VCYT Stock Holding History

Adams Street Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,405	Closed	-$50K	–	15
2017 Q1	$50K	Buy	+5,405	New	+$44.2K	0.01%	13

Other funds holding VCYT

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Adams Street Partners's VCYT Position: Q2 2017 in Review

Adams Street Partners sold out of Veracyte (VCYT) in Q2 2017, closing a stake of 5,405 shares — an estimated $50K sold.

Adams Street Partners first reported a position in VCYT in Q1 2017 and held it in 1 quarter. The position peaked at $50K in Q1 2017. 88 funds tracked by Wall St. Rank hold VCYT as of Q2 2017.

Adams Street Partners reported no remaining Veracyte position as of Q2 2017 after selling out during the quarter.
Adams Street Partners sold 5,405 Veracyte shares in Q2 2017, an estimated $50K.
Adams Street Partners first reported a position in Veracyte in Q1 2017 and held it in 1 quarter.
Adams Street Partners's Veracyte position peaked at $50K in Q1 2017.
88 funds tracked by Wall St. Rank held Veracyte as of Q2 2017.

Based on Adams Street Partners's 13F filing for Q2 2017, filed 3 Aug 2017.